These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2243187)

  • 21. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement.
    Anderson DC; Hughes BJ; Edwards MS; Buffone GJ; Baker CJ
    Pediatr Res; 1983 Jun; 17(6):496-502. PubMed ID: 6348689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
    Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL
    N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
    Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
    Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
    Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
    Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against Streptococcus agalactiae proteins c(alpha) and R4 in sera from pregnant women from Norway and Zimbabwe.
    Moyo SR; Maeland JA; Mudzori J
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1110-4. PubMed ID: 11687448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of type-specific group B streptococcal antibody by indirect immunofluorescence and prevention of vertical transmission by antibiotic therapy].
    Sugiyama M; Kojima M; Ito Y; Hori Y; Nishiyama Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Feb; 39(2):181-8. PubMed ID: 3546537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibodies to group B streptococci in maternal and cord sera].
    Kubota T; Takada M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):676-82. PubMed ID: 2527933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants.
    Dangor Z; Kwatra G; Izu A; Adrian P; Cutland CL; Velaphi S; Ballot D; Reubenson G; Zell ER; Lala SG; Madhi SA
    Vaccine; 2015 Nov; 33(48):6793-9. PubMed ID: 26478200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy.
    Dzanibe S; Kwatra G; Adrian PV; Kimaro-Mlacha SZ; Cutland CL; Madhi SA
    Sci Rep; 2017 Nov; 7(1):16454. PubMed ID: 29184151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroepidemiology of group B Streptococcus type II antibody specificity.
    Gray BM; Pritchard DG; Springfield JD; Benak RJ; Dillon HC
    Epidemiol Infect; 1988 Oct; 101(2):347-54. PubMed ID: 3053221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type III group B Streptococcus: functional interaction with IgG subclass antibodies.
    Givner LB; Baker CJ; Edwards MS
    J Infect Dis; 1987 Mar; 155(3):532-9. PubMed ID: 3543156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants.
    Dangor Z; Kwatra G; Izu A; Lala SG; Madhi SA
    Expert Rev Vaccines; 2015 Jan; 14(1):135-49. PubMed ID: 25242617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.
    Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY
    Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
    Baker CJ; Kasper DL
    N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple, quantitative, reproducible avidin-biotin ELISA for the evaluation of group B streptococcus type-specific antibodies in humans.
    Basham LE; Pavliak V; Li X; Hawwari A; Kotloff KL; Edelman R; Fattom A
    Vaccine; 1996 Apr; 14(5):439-45. PubMed ID: 8735557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional activity of class-specific antibodies to type III, group B streptococcus.
    Campbell JR; Baker CJ; Metzger TG; Edwards MS
    Pediatr Res; 1988 Jan; 23(1):31-4. PubMed ID: 3277150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological markers of the R4 protein of Streptococcus agalactiae.
    Maeland JA; Bevanger L; Lyng RV
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1305-10. PubMed ID: 16275945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections.
    Dangor Z; Lala SG; Kwatra G; Madhi SA
    Curr Opin Infect Dis; 2016 Jun; 29(3):262-7. PubMed ID: 26926474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.